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Venous thromboembolism - update 2019 Abstract. Abstract:The implication of new diagnostic algorithms in our daily clinical routine has simplified the diagnostic certainty, particularly in the case of exclusion of venous thromboembolism (VTE), so that even the general practitioner can already rule out venous thromboembolism with sufficient certainty. The introduction of risk scores in patients with a confirmed diagnosis can help to identify those patients who are at particular risk so you can monitor them. On the other hand, outpatient treatment of patients with pulmonary embolism in the low-risk category increases significantly. With the introduction of the new oral anticoagulants (NOAC), the treatment of these patients has been significantly simplified, and the risk of major bleeding compared to the vitamin K antagonists has been significantly reduced. For patients with paraneoplastic VTEs, the NOACs will also be an option in the future, which must be validated in studies even more precisely. Due to the low risk of bleeding NOACs in prophylactic dosing, the proportion of patients undergoing extended secondary prophylaxis will continue to increase in the future, reducing the risk of VTE recurrence.